Damora Therapeutics
DMRA
#5885
Rank
A$1.78 B
Marketcap
A$28.89
Share price
-0.83%
Change (1 day)
346.78%
Change (1 year)

Earnings for Damora Therapeutics (DMRA)

Earnings in 2026 (TTM): -A$0.39 Billion

According to Damora Therapeutics's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -A$0.3 Billion a decrease over its 2024 earnings that were of -A$30.51 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Damora Therapeutics from 2020 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$0.39 Billion30.14%
2025 -A$0.3 Billion880.41%
2024 -A$30.51 Million-44.2%
2023 -A$54.67 Million-37.77%
2022 -A$87.85 Million19.08%
2021 -A$73.78 Million48.55%
2020 -A$49.67 Million